Annual Retained Earnings
-$155.39 M
+$2.51 M+1.59%
December 31, 2023
Summary
- As of February 7, 2025, VNDA annual retained earnings is -$155.39 million, with the most recent change of +$2.51 million (+1.59%) on December 31, 2023.
- During the last 3 years, VNDA annual retained earnings has risen by +$41.94 million (+21.25%).
- VNDA annual retained earnings is now -1148.62% below its all-time high of -$12.45 million, reached on December 31, 2004.
Performance
VNDA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$169.38 M
-$5.32 M-3.25%
September 30, 2024
Summary
- As of February 7, 2025, VNDA quarterly retained earnings is -$169.38 million, with the most recent change of -$5.32 million (-3.25%) on September 30, 2024.
- Over the past year, VNDA quarterly retained earnings has dropped by -$9.84 million (-6.17%).
- VNDA quarterly retained earnings is now -366.23% below its all-time high of -$36.33 million, reached on December 31, 2005.
Performance
VNDA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
VNDA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.6% | -6.2% |
| 3 y3 years | +21.3% | -6.2% |
| 5 y5 years | +53.8% | -6.2% |
VNDA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +5.3% | -10.7% | +0.7% |
| 5 y | 5-year | at high | +29.6% | -10.7% | +23.2% |
| alltime | all time | -1148.6% | +57.0% | -366.2% | +53.1% |
Vanda Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$169.38 M(+3.2%) |
| Jun 2024 | - | -$164.06 M(+2.8%) |
| Mar 2024 | - | -$159.54 M(+2.7%) |
| Dec 2023 | -$155.39 M(-1.6%) | -$155.39 M(+1.6%) |
| Sep 2023 | - | -$152.99 M(-0.1%) |
| Jun 2023 | - | -$153.13 M(-1.0%) |
| Mar 2023 | - | -$154.65 M(-2.1%) |
| Dec 2022 | -$157.90 M(-3.8%) | -$157.90 M(-4.2%) |
| Sep 2022 | - | -$164.76 M(-1.9%) |
| Jun 2022 | - | -$168.03 M(-1.5%) |
| Mar 2022 | - | -$170.61 M(+3.9%) |
| Dec 2021 | -$164.18 M(-16.8%) | -$164.18 M(-4.1%) |
| Sep 2021 | - | -$171.25 M(-4.3%) |
| Jun 2021 | - | -$179.03 M(-5.1%) |
| Mar 2021 | - | -$188.68 M(-4.4%) |
| Dec 2020 | -$197.33 M(-10.6%) | -$197.33 M(-4.0%) |
| Sep 2020 | - | -$205.52 M(-2.8%) |
| Jun 2020 | - | -$211.47 M(-4.0%) |
| Mar 2020 | - | -$220.18 M(-0.2%) |
| Dec 2019 | -$220.66 M(-34.4%) | -$220.66 M(-1.9%) |
| Sep 2019 | - | -$224.88 M(-30.9%) |
| Jun 2019 | - | -$325.30 M(-3.4%) |
| Mar 2019 | - | -$336.83 M(+0.2%) |
| Dec 2018 | -$336.22 M(-7.0%) | -$336.22 M(-3.0%) |
| Sep 2018 | - | -$346.58 M(-2.0%) |
| Jun 2018 | - | -$353.75 M(-1.3%) |
| Mar 2018 | - | -$358.36 M(-0.8%) |
| Dec 2017 | -$361.43 M(+4.5%) | -$361.43 M(+0.5%) |
| Sep 2017 | - | -$359.59 M(+1.3%) |
| Jun 2017 | - | -$355.04 M(+0.4%) |
| Mar 2017 | - | -$353.50 M(+2.2%) |
| Dec 2016 | -$345.86 M(+5.5%) | -$345.86 M(+0.2%) |
| Sep 2016 | - | -$345.25 M(+0.1%) |
| Jun 2016 | - | -$344.82 M(+1.4%) |
| Mar 2016 | - | -$340.21 M(+3.8%) |
| Dec 2015 | -$327.85 M(+13.8%) | -$327.85 M(+4.7%) |
| Sep 2015 | - | -$313.05 M(+3.1%) |
| Jun 2015 | - | -$303.59 M(+1.8%) |
| Mar 2015 | - | -$298.20 M(+3.5%) |
| Dec 2014 | -$287.98 M(-6.6%) | -$287.98 M(-19.5%) |
| Sep 2014 | - | -$357.70 M(+0.4%) |
| Jun 2014 | - | -$356.28 M(+6.4%) |
| Mar 2014 | - | -$334.70 M(+8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | -$308.17 M(+5.9%) | -$308.17 M(+1.5%) |
| Sep 2013 | - | -$303.74 M(+1.8%) |
| Jun 2013 | - | -$298.36 M(+1.0%) |
| Mar 2013 | - | -$295.28 M(+1.4%) |
| Dec 2012 | -$291.11 M(+10.5%) | -$291.11 M(+2.2%) |
| Sep 2012 | - | -$284.74 M(+1.9%) |
| Jun 2012 | - | -$279.41 M(+3.0%) |
| Mar 2012 | - | -$271.40 M(+3.0%) |
| Dec 2011 | -$263.44 M(+3.9%) | -$263.44 M(+2.1%) |
| Sep 2011 | - | -$257.92 M(+1.2%) |
| Jun 2011 | - | -$254.85 M(+0.5%) |
| Mar 2011 | - | -$253.50 M(-0.1%) |
| Dec 2010 | -$253.64 M(-2.8%) | -$253.64 M(-0.9%) |
| Sep 2010 | - | -$255.84 M(-1.2%) |
| Jun 2010 | - | -$259.02 M(-0.5%) |
| Mar 2010 | - | -$260.30 M(-0.2%) |
| Dec 2009 | -$260.83 M(+15.9%) | -$260.83 M(+3.7%) |
| Sep 2009 | - | -$251.60 M(+3.2%) |
| Jun 2009 | - | -$243.87 M(+5.4%) |
| Mar 2009 | - | -$231.48 M(+2.9%) |
| Dec 2008 | -$224.97 M(+29.4%) | -$224.97 M(+3.5%) |
| Sep 2008 | - | -$217.47 M(+5.3%) |
| Jun 2008 | - | -$206.60 M(+7.0%) |
| Mar 2008 | - | -$193.11 M(+11.0%) |
| Dec 2007 | -$173.91 M(+74.2%) | -$173.91 M(+13.5%) |
| Sep 2007 | - | -$153.16 M(+16.7%) |
| Jun 2007 | - | -$131.22 M(+13.9%) |
| Mar 2007 | - | -$115.23 M(+15.4%) |
| Dec 2006 | -$99.84 M(+174.8%) | -$99.84 M(+13.5%) |
| Sep 2006 | - | -$87.95 M(+16.0%) |
| Jun 2006 | - | -$75.82 M(+39.3%) |
| Mar 2006 | - | -$54.45 M(+49.9%) |
| Dec 2005 | -$36.33 M(+191.9%) | -$36.33 M |
| Dec 2004 | -$12.45 M(-78.4%) | - |
| Dec 2003 | -$57.62 M(-66.0%) | - |
| Dec 2002 | -$169.63 M(+77.3%) | - |
| Dec 2001 | -$95.65 M(+5.8%) | - |
| Dec 2000 | -$90.37 M(-22.8%) | - |
| Dec 1999 | -$117.00 M(-11.9%) | - |
| Dec 1998 | -$132.80 M(+21.2%) | - |
| Dec 1997 | -$109.60 M(+41.2%) | - |
| Dec 1996 | -$77.60 M(-2.3%) | - |
| Dec 1995 | -$79.40 M(-0.1%) | - |
| Dec 1994 | -$79.50 M | - |
FAQ
- What is Vanda Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual retained earnings year-on-year change?
- What is Vanda Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly retained earnings year-on-year change?
What is Vanda Pharmaceuticals annual retained earnings?
The current annual retained earnings of VNDA is -$155.39 M
What is the all time high annual retained earnings for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual retained earnings is -$12.45 M
What is Vanda Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, VNDA annual retained earnings has changed by +$2.51 M (+1.59%)
What is Vanda Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of VNDA is -$169.38 M
What is the all time high quarterly retained earnings for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly retained earnings is -$36.33 M
What is Vanda Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, VNDA quarterly retained earnings has changed by -$9.84 M (-6.17%)